Cyfuse Biomedical K.K.

Direct answer

Cyfuse Biomedical K.K. is publicly traded on JPX under the ticker 4892.T.

Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which...

Can you invest in Cyfuse Biomedical K.K.?

Yes. Cyfuse Biomedical K.K. is publicly traded on JPX under the ticker 4892.T.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Cyfuse Biomedical K.K.

Detailed equity research is provided by MarketSnap.